Immunic Therapeutics

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

51-100 employees
Biotechnology
Public Company

Open Positions14

Location: Remote - USFull-TimeBiotechnologyPosted
  • Design, implement, and own gross-to-net revenue accounting for the first commercial product, including reserves, accruals, and related discounts and fees.
  • Develop audit-ready gross-to-net estimation methodologies, roll-forwards, and true-up processes applying ASC 606 variable consideration principles.
  • Partner with Market Access, Trade, and Government Pricing to align contract terms, channel data, and government pricing calculations with accounting.
  • Establish inventory accounting and costing, including pre-launch inventory capitalization, standard costing, CMO/3PL reconciliations, and excess and obsolescence reserves.
  • Lead the monthly, quarterly, and annual close, including clinical trial accruals, stock-based compensation, leases, and other technical areas.
  • Prepare and review Forms 10-Q and 10-K, footnotes, and supporting schedules with the CFO and SEC reporting resources.
  • Design and maintain a SOX-compliant internal control environment for commercial processes.
  • Serve as the primary liaison with external auditors and prepare technical accounting memos for new transactions and commercial arrangements.
  • Support selection and implementation of a commercial-ready ERP and related systems, including gross-to-net/revenue management and 3PL integrations.
  • Build, lead, and develop the accounting team; manage outsourced accounting partners; and partner with FP&A on budgeting, forecasting, and launch-related financial analysis.
Showing 1 of 14 positions

Overview

Immunic Therapeutics is a clinical-stage biopharmaceutical company that develops selective oral immunology therapies for chronic inflammatory and autoimmune diseases. The company is developing three small molecule product candidates. IMU-838 is in Phase 3 clinical trials for relapsing multiple sclerosis, and is also under development for ulcerative colitis, Crohn's disease, and primary sclerosing cholangitis. IMU-935 is targeted for development in psoriasis, castration-resistant prostate cancer, and Guillain-Barré syndrome. IMU-856 is being developed for gastrointestinal diseases such as celiac disease and other conditions involving bowel barrier dysfunction and is entering Phase 2 clinical trials. IMU-381 is a next-generation small molecule in preclinical development for gastrointestinal diseases. The company is headquartered in New York, NY, USA, with research and development activities managed from Gräfelfing, Germany.

Culture

  • Offers flexible working hours
  • Offers hybrid work options
  • Some roles are designated as Remote - US

Technology Story

The company utilizes SPF, DNSSEC, SSL by Default, IPv6, Microsoft Exchange Online, Cloudflare CDN, Cloudflare, Office 365 Mail, and Apache. The Associate Director, Clinical Study Lead role requires knowledge of ICH-GCP, applicable FDA, EMA, and local regulatory requirements.

Why Work Here

Immunic Therapeutics is an Equal Opportunity Employer. Employment decisions are based on qualifications, merit, and business needs. The company does not accept unsolicited resumes from external agencies or recruiters.

Benefits and Perks

  • Offers equity
  • Offers bonus
  • Compensation for the Associate Director, Clinical Study Lead role ranges from $180,000 to $210,000
  • Grants for public transport
  • Grants for fitness
  • Company pension
  • Access to childcare through a membership at BioKids Martinsried

Tech Stack

web_servermxserver

Similar Companies